Hansoh Bio (603077.SH) released its first-half financial results, with a net profit attributable to shareholders of 51.77 million yuan, a decrease of 73.07%.

The Zhisheng Finance APP has released the 2025 semi-annual report for Hengbang Biotechnology (603077.SH). The company's operating income was 3.921 billion yuan, a decrease of 19.13% year-on-year. Net profit attributable to shareholders of the listed company was 51.7715 million yuan, a decrease of 73.07% year-on-year. Net profit attributable to shareholders of the listed company excluding non-recurring gains and losses was 46.9801 million yuan, a decrease of 74.88% year-on-year. Basic earnings per share was 0.0065 yuan.